These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6540170)

  • 21. Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control.
    Callaghan N; O'Callaghan M; Duggan B; Feely M
    J Neurol Neurosurg Psychiatry; 1978 Oct; 41(10):907-12. PubMed ID: 731240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Water intoxication in epileptic patients receiving carbamazepine.
    Perucca E; Garratt A; Hebdige S; Richens A
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):713-8. PubMed ID: 681958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy.
    Specht U; May TW; Rohde M; Wagner V; Schmidt RC; Schütz M; Wolf P
    Arch Neurol; 1997 Apr; 54(4):427-31. PubMed ID: 9109744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
    Babaei A; Eslamai MH
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):121-5. PubMed ID: 17323792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study on carbamazepine levels, including estimation of 10-11 epoxy-carbamazepine and levels in free plasma and saliva.
    Tomlin PI; McKinlay I; Smith I
    Dev Med Child Neurol; 1986 Dec; 28(6):713-8. PubMed ID: 3817310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on carbamazepine serum level in epileptic patients treated only with carbamazepine: with special reference to its efficacy and side effects (author's transl)].
    Kaneko S; Suzuki K; Fukushima Y; Sato T
    Seishin Shinkeigaku Zasshi; 1978 Sep; 80(9):537-60. PubMed ID: 724824
    [No Abstract]   [Full Text] [Related]  

  • 27. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian carbamazepine toxicity.
    Haefeli WE; Meyer PG; Lüscher TF
    Epilepsia; 1994; 35(2):400-2. PubMed ID: 8156964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbamazepine-10,11-epoxide in epilepsy. A pilot study.
    Tomson T; Almkvist O; Nilsson BY; Svensson JO; Bertilsson L
    Arch Neurol; 1990 Aug; 47(8):888-92. PubMed ID: 2375696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dosage frequency of carbamazepine on drug serum levels in epileptic patients.
    Ghose K; Fry DE; Christfides JA
    Eur J Clin Pharmacol; 1983; 24(3):375-81. PubMed ID: 6861851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
    Wang RB; Liu LT; Yiu CH; Chang TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute toxic reaction to carbamazepine: clinical effects and serum concentrations.
    Tibballs J
    J Pediatr; 1992 Aug; 121(2):295-9. PubMed ID: 1640302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?
    Besag FM; Berry DJ; Pool F; Newbery JE; Subel B
    Epilepsia; 1998 Feb; 39(2):183-7. PubMed ID: 9577998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and pharmacokinetics of carbamazepine oral loading doses.
    Cohen H; Howland MA; Luciano DJ; Rubin RN; Kutt H; Hoffman RS; Leung LK; Devinsky O; Goldfrank LR
    Am J Health Syst Pharm; 1998 Jun; 55(11):1134-40. PubMed ID: 9626375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once daily dosage versus divided daily doses of carbamazepine therapy in epileptic patients: a pilot study.
    Ghose K; Dawson M; Fry DE; Christofides JA
    Pharmatherapeutica; 1981; 3(1):71-8. PubMed ID: 7033994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impairment of psychomotor function at modest plasma concentrations of carbamazepine after administration of the liquid suspension to naive subjects.
    Wildin JD; Pleuvry BJ; Mawer GE
    Br J Clin Pharmacol; 1993 Jan; 35(1):14-9. PubMed ID: 8448063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of carbamazepine on psychomotor performance in näive subjects.
    MacPhee GJ; Goldie C; Roulston D; Potter L; Agnew E; Laidlaw J; Brodie MJ
    Eur J Clin Pharmacol; 1986; 30(1):37-42. PubMed ID: 3709630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of josamycin on carbamazepine kinetics.
    Vinçon G; Albin H; Demotes-Mainard F; Guyot M; Bistue C; Loiseau P
    Eur J Clin Pharmacol; 1987; 32(3):321-3. PubMed ID: 3595706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing plasma carbamazepine concentrations.
    Lander CM; Eadie MJ; Tyrer JH
    Clin Exp Neurol; 1977; 14():184-93. PubMed ID: 616596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.